TDAX yields 5.15% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 2
Combined, TDAX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TDAX + MRK for your $10,000?
TDAX seeks to deliver leveraged exposure equal to 130% of the daily performance of TDAQ, with portfolio exposure reset at the close of each trading day. The fund primarily uses swap agreements and, at times, exchange-traded call options to maintain its targeted daily exposure, rebalancing as needed based on market movements. Because exposure is reset daily, returns over periods longer than one trading day reflect the compounding of daily results and can differ materially from TDAQs performance over the same timeframe. The fund pursues its objective regardless of market conditions and does not take defensive positions, which can lead to high portfolio turnover. As a leveraged product, performance is highly sensitive to short-term price movements, and a sufficiently large adverse move in TDAQ during a single trading day could result in a complete loss of value.
Full TDAX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.